[6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice

Toxicology Letters

Volumn 210, Issue 1, 2012, Pages 34-43

  Chakraborty, Debrup ^a   Mukherjee, Avinaba ^a   Sikdar, Sourav ^a   Paul, Avijit ^a   Ghosh, Samrat ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

6 Gingerol; GLUT4; Hyperglycemia; Insulin signaling; Oxidative stress; Sodium arsenite

Indexed keywords

(6) GINGEROL; ARSENITE SODIUM; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GINGER; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIVER CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARSENITES; BLOOD GLUCOSE; CATALASE; CATECHOLS; FATTY ALCOHOLS; GLUTATHIONE PEROXIDASE; HEPATOCYTES; INSULIN; INSULIN-SECRETING CELLS; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS; SUPEROXIDE DISMUTASE;

MUS; ZINGIBER OFFICINALE;

EID: 84856560488     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.01.002     Document Type: Article

References (49)

1. Aebi H. Catalase in vitro. Methods in Enzymol, vol. 105 1984, 121-126. L. Packer (Ed.).
2. Badreldin H.A., Gerald B., Musbah O.T., Abderrahim N. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem. Toxicol. 2008, 46:409-420.
3. Banerjee P., Biswas S.J., Belon P., Khuda-Bukhsh A.R. A potentized homeopathic drug, arsenicum album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice. J. Vet. Med. 2007, 54:370-376.
4. Belon P., Banerjee P., Choudhury C.S., Banerjee A., Biswas J.S., Karmakar R.S., Pathak S., Guha B., Chatterjee S., Bhattacharjee N., Das K.J., Khuda-Bukhsh A.R. Can administration of potentized homeopathic remedy, arsenicum album, alter antinuclear antibody (ANA) titer in people living in high-risk arsenic contaminated areas? I. A correlation with certain hematological parameters. eCAM 2006, 3:99-107.
5. Benzie I.F.F., Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999, 299:15-27.
6. Bhattacharyya S.S., Paul S., Mandal S.K., Banerjee A., Boujedaini N., Khuda-Bukhsh A.R. A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice. Eur. J. Pharmacol. 2009, 614:128-136.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976, 72:248-254.
8. Cemek M., Kaga S., Simsek N., Büyükokuroglu M.E., Konuk M. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. Nat. Med. 2008, 62:284-293.
9. Chakraborty D., Samadder A., Dutta S., Khuda-Bukhsh A.R. Antihyper-glycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade. Exp. Biol. Med. 2012, 237:64-76.
10. Chang I., Kim S., Kim J.Y., Cho N., Kim Y.H., Kim H.S., Lee M.K., Kim K.W., Lee M.S. NF-kβ prevents β cell death and autoimmune diabetes in NOD mice. Diabetes 2003, 52:1169-1175.
11. Connell D., Sutherland M. A reexamination of gingerol, shogaol, and zingerone, the pungent principles of ginger. Aust. J. Chem. 1969, 22:1033-1043.
12. Das J., Ghosh J., Manna P., Sil P.C. Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCd-JNK pathway. PLoS One 2010, 5:1-19.
13. Diaz-Villaseñor A., Sanchez-Soto M.C., Cebrian M.E., Ostrosky-Wegman P., Hiriart M. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol. Appl. Pharmacol. 2006, 214:30-34.
14. Ellman G.L. Tissue sulfhydryl group. Arch. Biochem. Biophys. 1959, 82:70-77.
15. Eto K., Tsubamoto Y., Terauchi Y., Sugiyama T., Kishimoto T., Takahashi N., Yamauchi N., Kubota N., Murayama S., Aizawa T., Akanuma Y., Aizawa S., Kasai H., Yazaki Y., Kadowaki T. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 1999, 283:981-985.
16. Folli F., Corradi D., Fanti P., Davalli A., Paez A., Giaccari A., Perego C., Muscogiuri G. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr. Diabet. Rev. 2011, 7:313-324.
17. Fridovich I. Superoxide dismutase: an adaptation to a paramagnetic gas. J. Biol. Chem. 1989, 264:7761-7764.
18. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 1999, 49:5-14.
19. Gurnell M. PPAR gamma and metabolism: insights from the study of human genetic variants. Clin. Endocrinol. (Oxf.) 2003, 59:267-277.
20. Izquierdo-Vega J.A., Soto C.A., Sanchez-Pena L.C., De Vizcaya-Ruiz A., Del Razo L.M. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol. Lett. 2006, 160:135-142.
21. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., Rhodes C.J., Valko M. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. 2011, 31:95-107.
22. Jones F.T. A broad view of arsenic. Poult. Sci. 2007, 86:2-14.
23. Khuda-Bukhsh A.R., Pathak S., Guha B., Karmakar S.R., Das J.K., Banerjee P., Biswas S.J., Mukherjee P., Bhattacharjee N., Choudhury S.C., Banerjee A., Bhadra S., Mallick P., Chakrabarti J., Mandal B. Can homeopathic arsenic remedy combat arsenic poisoning in humans exposed to groundwater arsenic contamination? A preliminary report on first human trial. eCAM 2005, 2:537-548.
24. Kiuchi F., Iwakami S., Shibuya M., Hanaoka F., Sanakawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 1992, 40:387-391.
25. Leonard A., Lauwerys R.R. Carcinogenicity, teratogenicity, and mutagenicity of arsenic. Mutat. Res. 1980, 75:49-62.
26. Liu G., Zhang V., Bode A.M., Ma W.Y., Dong Z. Phosphorylation of 4E-BP1 is mediated by the p38/MSK1 pathway in response to UVB irradiation. J. Biol. Chem. 2001, 277:8810-8816.
27. Longnecker M.P., Daniels J.L. Environmental contaminants as etiologic factors for diabetes. Environ. Health Perspect. 2001, 109:871-876.
28. Mandal S.K., Biswas R., Bhattacharyya S.S., Paul S., Dutta S., Pathak S., Khuda-Bukhsh A.R. Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur. J. Pharmacol. 2009, 626:1-8.
29. Manna P., Sinha M., Sil P.C. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology 2009, 257:53-63.
30. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ. Health Perspect. 2006, 114:641-648.
31. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 2002, 110:331-336.
32. Ratha J., Majumder K.N., Mandal S.K., Bera R., Sarkar C., Saha B., Mandal C., Saha K.D., Bhadra R. A sphingolipid rich lipid fraction isolated from attenuated donovani promastigote induces apoptosis in mouse and human melanoma cells in vitro. Mol. Cell Biochem. 2006, 290:113-123.
33. Rondinone C.M. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006, 29:81-90.
34. Santra A., Maiti A., Chowdhury A., Guha mazumder D.N. Oxidative stress in liver of mice exposed to arsenic contaminated water. Indian J. Gastroenterol. 2000, 19:112-115.
35. Seqlen P. Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion. Exp. Cell. Res. 1973, 76:25-30.
36. Silbergeld E.K., Pastor-Barriuso R., Guallar E., Jama P.H. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
37. Singh A.B., Akanksha Singh N., Maurya R., Srivastava A.K. Anti-hyperglycemic, lipid lowering and anti-oxidant properties of [6]-gingerol in db/db mice. Int. J. Med. Med. Sci. 2009, 1:536-544.
38. Srivas K.C. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: in vitro study. Prostaglandins Leukot. Med. 1984, 13:227-235.
39. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., Little C.B., Last K., Farmer P.J., Campbell I.K., Fourie A.M., Fosang A.J. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
40. Sun X., Li B., Li X., Wang Y., Xu Y., Jin Y., Piao F., Sun G. Effects of sodium arsenite on catalase activity, gene and protein expression in HaCaT cells. Toxicology 2006, 20:1139-1144.
41. Taylor R. The nature of type 2 diabetes: the role for new agents. Int. J. Clin. Pract. Suppl. 1999, 104:18-20.
42. Tchounwou P.B., Wilson B.A., Ishaque A. Important considerations in the development of public health advisories for arsenic and arsenic containing compounds in drinking water. Rev. Environ. Health 1999, 14:1-19.
43. Tjendraputra E., Tran V.H., Liu-Brennan D., Roufogalis B.D., Duke C.C. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg. Chem. 2001, 29:156-163.
44. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:453-463.
45. Vijayakumar M.V., Singh S., Chhipa R.R., Bhat M.K. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br. J. Pharmacol. 2005, 146:41-48.
46. Walton F.S., Harmon A.W., Paul D.S., Drobná Z., Patel Y.M., Styblo M. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 2004, 198:424-433.
47. Wang S.L., Pan W.H., Hwu C.M., Ho L.T., Lo C.H., Lin S.L., Jong Y.S. Incidence of NIDDM and the effects of gender, obesity and hyperinsulinaemia in Taiwan. Diabetologia 1997, 40:1431-1438.
48. Yousef M.I., El-Demerdash F.M., Radwan F.M.E. Sodium arsenite induced biochemical perturbations in rats: ameliorating effect of curcumin. Food Chem. Toxicol. 2008, 46:3506-3511.
49. Zimmet P. Type-2 non-insulin-dependent diabetes-an epidemiological overview. Diabetologia 1982, 22:399-411.